首页> 外文期刊>BMC Cancer >Preoperative controlling nutritional status (CONUT) score as a predictor of long-term outcome after curative resection followed by adjuvant chemotherapy in stage II-III gastric Cancer
【24h】

Preoperative controlling nutritional status (CONUT) score as a predictor of long-term outcome after curative resection followed by adjuvant chemotherapy in stage II-III gastric Cancer

机译:术前控制营养状况(Conut)评分作为治疗切除后的长期结果的预测因子,然后在第III期胃癌中进行佐剂化疗

获取原文
           

摘要

The prognostic value of preoperative controlling nutritional status (CONUT) has been reported in many malignancies. In present study, we aimed to clarify the prognostic impact of CONUT in gastric cancer (GC) receiving curative resection and adjuvant chemotherapy. We retrospectively reviewed 697 consecutive patients undergoing curative surgery followed by adjuvant chemotherapy for Stage II-III GC between November 2000 and September 2012. Patients were classified into high (≥3) and low (≤2) CONUT groups according to the receiver operating characteristic (ROC) analysis. Of the included patients, 217 (31.1%) belonged to the high CONUT group. The high CONUT group had a significantly lower 5-year cancer-specific survival (CSS) rate than the low CONUT group (39.3 vs. 55.5%, P??0.001). High CONUT score was significantly associated with larger tumor size, more lymph node metastasis, and poorer nutritional status, including lower body mass index (BMI), higher prognostic nutritional index (PNI) and the presence of preoperative anemia (all P??0.05). Multivariate analysis revealed that CONUT score was an independent prognostic factor (HR: 1.553; 95% CI: 1.080-2.232; P?=?0.017). Of note, in the low PNI group, CONUT score still effectively stratified CSS (P?=?0.016). Furthermore, the prognostic significance of CONUT score was also maintained when stratified by TNM stage (all P??0.05). CONUT score is considered a useful nutritional marker for predicting prognosis in stage II-III GC patients undergoing curative resection and adjuvant chemotherapy, and may help to facilitate the planning of preoperative nutritional interventions.
机译:许多恶性肿瘤都报道了术前控制营养状况(康圈)的预后价值。在目前的研究中,我们旨在阐明Conut在胃癌(GC)接受治疗切除和佐剂化疗的预后影响。我们回顾性地审查了697名患有治愈手术的患者,然后在2000年11月和2012年9月期间进行辅助化疗。根据接收器操作特性,患者分为高(≥3)和低(≤2)顿康那件组( ROC)分析。包含的患者,217名(31.1%)属于高康纳因组织。高康圈组的5年癌症特异性存活率(CSS)率明显低于低康康圈组(39.3〜55.5%,P?<0.001)。高符合高分子分数与较大的肿瘤大小明显相关,淋巴结转移和较差的营养状况,包括较低的体重指数(BMI),更高的预后营养​​指数(PNI)以及术前贫血(所有P?<?0.05 )。多变量分析显示,截取分数是独立的预后因子(HR:1.553; 95%CI:1.080-232; P?= 0.017)。注意,在低PNI组中,Contut评分仍然有效分层CSS(P?= 0.016)。此外,当通过TNM阶段分层(所有p?<β05)分层时也保持了截止得分的预后意义。 Contut得分被认为是预测阶段III-III患者的预后的有用营养标志物,并有助于促进术前营养干预的规划。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号